Cernostics, Geisinger Health to Develop Personalized Cancer Dx
June 21, 2010
Cernostics, Geisinger Health to Develop Personalized Cancer Dx
The focus of the partnership is on developing cancer diagnostics that may lead to better prediction of disease progression, and the identification of patients who may benefit from specific cancer treatments.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.